🔎 Trials Near Me

Akèy › Kansè poumon selil ti › Michigan › Ann Arbor

Etid klinik pou Kansè poumon selil ti nan Ann Arbor, MI

6 etid pou Kansè poumon selil ti ap chèche patisipan nan sit nan ak bò kote Ann Arbor (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy

Ap rekriteFaz 3
  • Veterans Affairs Ann Arbor Healthcare System, Ann Arbor
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07472517

Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)

Ap rekriteFaz 1
  • Trinity Health Saint Joseph Mercy Ann Arbor, Ann Arbor
Laj 18 ak plis · Tout sèks · Mizajou Jun 26, 2026 · NCT06598306

Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study

Ap rekriteFaz 2
  • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi lwen
  • Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · 15 mi lwen
  • Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · 18 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Mar 30, 2026 · NCT06769126

Biomarker Directed Trial of Temozolomide and Stenoparib in Relapsed SCLC

Ap rekriteFaz 1/2
  • VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor
Laj 18 ak plis · Tout sèks · Mizajou Mar 11, 2026 · NCT06681220

Study of Bevacizumab in Combination With Chemoimmunotherapy and Atezolizumab in Patients With Extensive Stage Small Cell Lung Cancer and Liver Metastases

Ap rekriteFaz 2
  • V.A. Ann Arbor Healthcare System, Ann Arbor
  • University of Michigan, Ann Arbor
Tout laj · Tout sèks · Mizajou Nov 17, 2025 · NCT05588388

A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit

Ap rekriteFaz 1
  • University of Michigan Hospitals, Ann Arbor
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2025 · NCT06805825

Etid Kansè poumon selil ti nan lòt vil

Lòt etid nan Ann Arbor

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.